آموزش و اخلاق در پرستاری
Education and Ethics In Nursing ISSN: 2322-5300

بررسی تأثیر برنامۀ جامع حمایتی پرستار بر اضطراب مرگ و تبعیت از درمان هورمونی در زنان مبتلا به سرطان سینه: پروتکل مطالعۀ آر سی تی

https://doi.org/10.22034/ethic.2024.2034646.1087
دوره 13، ویژه نامه ارتقا سلامت
تیر 1403
صفحه 42-52
آموزش و اخلاق در پرستاری

نوع مقاله : پروتکل مطالعه (protocol study)

نویسندگان

سعیده رئیسی 1
مهدی کریم یار جهرمی 2
مجید اکرمی 3
محسن حجت 2

1 کارشناسی ارشد، دانشکده پرستاری مامایی،دانشگاه علوم پزشکی جهرم، جهرم، ایران

2 استادیار پرستاری، گروه پرستاری، دانشکده پرستاری،دانشگاه علوم پزشکی جهرم، ایران

3 مرکز تحقیقات بیماریهای پستان شیراز، دانشگاه علوم پزشکی شیراز، ایران

چکیده
مقدمه: سرطان، یکی از مشکلات مهم در سراسر جهان است که تعداد مبتلایان آن روزبه ­روز در حال افزایش می ­باشد. تبعیت از درمان دارویی به چالشی برای متخصصان پزشکی و دانشمندان پرستاری تبدیل شده است. عدم کنترل اضطراب مرگ بیماران سرطانی می­تواند، باعث مشکلات بزرگی در آن­ها شود؛ بنابراین پژوهش حاضر، با هدف تعیین تأثیر برنامۀ جامع حمایتی پرستار بر اضطراب مرگ و تبعیت از درمان هورمونی در زنان مبتلا به سرطان سینه انجام شد.
روش کار: پژوهش حاضر، از نوع کارآزمایی بالینی بود که با همکاری 70 نفر از بیماران تحت هورمون درمانی( 1402) طراحی شد. برنامۀ جامع حمایتی در شش جلسه (آشنایی با هورمون درمانی، تأثیر معنویت در سرطان، آموزش تکنیک­ های کاهش اضطراب، تأثیر تغذیه و تحرک در سرطان سینه و آشنایی با مسائل جنسی در سرطان) به­ صورت حضوری و مجازی با حضور خانوادۀ بیمار پیشنهاد گردید. پرسشنامۀ تبعیت دارویی و اضطراب مرگ تمپلر قبل،  بلافاصله و یک ماه بعد از مداخله توسط کمک محقق پر شد. داده­ های کیفی با تست­های غیر پارامتریک و داده­ های کمی در صورت داشتن نرمالیتی­(تست چولگی دادها) با تست­های پارامتریک(تی مستقل و آزمون اندازه­ های تکراری) و در غیر این صورت، با تست­ های نان پارامتریک (ویلکاکسون و فریدمن) توسط نرم افزار spss 21، مورد تجزیه و تحلیل قرار گرفتند.
بحث: این کارآزمایی بالینی می ­تواند، اثر برنامۀ جامع حمایتی پرستار را بر اضطراب مرگ و تبعیت از درمان هورمونی در زنان مبتلا به سرطان سینه ارزیابی کند و شواهدی لازم است که برای اجرای چنین برنامه ­های حمایتی در زمینۀ سرطان سینه ارائه شود تا ضمن توسعۀ نقش پرستار در کلینیک­ های تخصصی سرطان شناسی، باعث بهبود مراقبت از بیماران گردد.
کد آر سی تی:IRCT20240120060738N1

کلیدواژه‌ها

مراقبت حمایتی
اضطراب مرگ
هورمون درمانی
تبعیت از درمان
سرطان سینه

عنوان مقاله English

Investigating the Effect of a Comprehensive Nurse Support Program on Death Anxiety and Adherence to Hormone Therapy in Women with Breast Cancer: RCT Study Protocol

نویسندگان English

Saedeh Raiesi 1
Mahdi karimyar jahromi 2
Majid Akrami 3
Mohsen Hojat 2
1 Master, Department of Nursing, School of Nursing, Jahrom University of Medical Sciences Jahrom, Iran
2 Department of Nursing, School of Nursing, Jahrom University of Medical Sciences Jahrom, Iran
3 MD Breast Diseases Research Center, Shiraz University Of Medical Sciences, Shiraz, Iran
چکیده English

Introduction: Cancer is a major global issue, with the number of patients increasing daily. Adherence to drug treatment has become a challenge for medical professionals and nursing scientists. Failure to manage the death anxiety of cancer patients can lead to significant problems. Therefore, this study was conducted with the aim of determining the impact of a nurse's comprehensive support program on death anxiety and adherence to hormone therapy in women with breast cancer.
Methods: This clinical trial study was designed with the participation of 70 patients undergoing hormone therapy in 2023. A comprehensive support program consisting of six sessions (covering familiarity with hormone therapy, the impact of spirituality on cancer, training in anxiety reduction techniques, the impact of nutrition and exercise on breast cancer, and familiarity with sexual issues in cancer) offered in person and virtually with the presence of the patient's family. The Templer Medication Adherence and Death Anxiety Questionnaire was filled in by the researcher's assistant before, immediately after, and one month after the intervention. Qualitative dataanalyzed using non-parametric tests, while quantitative data analyzed using parametric tests (independent t-tests for repeated measures if data was normally distributed, and non-parametric tests like Wilcoxon-Friedman if not) with SPSS 21 software.
Discussion: This clinical trial assess the impact of a nurse's comprehensive support program on death anxiety and adherence to hormone therapy in women with breast cancer; and evidence is required to be provided  for the implementation of such support programs in field of breast cancer and enhancing the role of nurses in oncology clinics to improve patient care.
RCT Code: IRCT20240120060738N1

کلیدواژه‌ها English

  • Supportive Care
  • Death Anxiety
  • Hormone Therapy
  • Adherence to Treatment
  • Breast Cancer
  1. 1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast. 2022;66:15-23.
  2. 2. Wang Y-J, Wang F, Yu L-X, Xiang Y-J, Zhou F, Huang S-Y, et al. Worldwide review with meta-analysis of women’s awareness about breast cancer. Patient Education and Counseling. 2022;105(7):1818-27.
  3. 3. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy. 2019:151-64.
  4. 4. Wang X, Wang N, Zhong L, Wang S, Zheng Y, Yang B, et al. Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients. Molecular psychiatry. 2020;25(12):3186-97.
  5. 5. Lin C, Clark R, Tu P, Bosworth HB, Zullig LL. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers. Breast cancer research and treatment. 2017;165:247-60.
  6. 6. Moon Z, Moss-Morris R, Hunter MS, Carlisle S, Hughes LD. Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient preference and adherence. 2017:305-22.
  7. 7. Yussof I, Tahir NAM, Hatah E, Shah NM. Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. The Breast. 2022;62:22-35.
  8. 8. Soleimani MA, Bahrami N, Allen K-A, Alimoradi Z. Death anxiety in patients with cancer: A systematic review and meta-analysis. European Journal of Oncology Nursing. 2020;48:101803.
  9. 9. SHARIFI SAKI S, Alipor A, Aghayuosefi A, Mohamadi MR, Ghobari Bonab B. The Relationship between Self-Compassion with Depression in Women with Breast Cancer with Mediation Death Anxiety. Quarterly journal of health psychology. 2019;8(29):52-67.
  10. 10. Yousefi Afrashteh M, Masoumi S. Psychological well-being and death anxiety among breast cancer survivors during the Covid-19 pandemic: the mediating role of self-compassion. BMC Women's Health. 2021;21:1-8.
  11. 11. Barjoee LK, Amini N, Keykhosrovani M, Shafiabadi A. Effectiveness of positive thinking training on perceived stress, metacognitive beliefs, and death anxiety in women with breast cancer: perceived stress in women with breast cancer. Archives of Breast Cancer. 2022:195-203.
  12. 12. Bahrami M, Behbahani MA. The effect of a health literacy promotion program on the level of health literacy and death anxiety in women with breast cancer. Iranian Journal of Nursing and Midwifery Research. 2019;24(4):286-90.
  13. 13. Goerling U, Bergelt C, Müller V, Mehnert-Theuerkauf A. Psychosocial distress in women with breast cancer and their partners and its Impact on supportive care needs in partners. Frontiers in Psychology. 2020;11:564079.
  14. 14. Jordan K, Feyer P, Höller U, Link H, Wörmann B, Jahn F. Supportive treatments for patients with cancer. Deutsches Ärzteblatt International. 2017;114(27-28):481.
  15. 15. Waks AG, Winer EP. Breast cancer treatment: a review. Jama. 2019;321(3):288-300.
  16. 16. Grenier N, Lebel V, Gill M, Mullen T, Mitchinson K, Sebborn K, et al. Effectiveness of a nursing support program for patients with recurrent ovarian cancer receiving pegylated liposomal doxorubicin (Caelyx®/Doxil®). Canadian Oncology Nursing Journal/Revue canadienne de soins infirmiers en oncologie. 2007;17(3):133-6.
  17. 17. Banaee B, Sanchooli A, Kiani F. The Effect of Couple Training on Treatment Adherence of Breast Cancer Patients Undergoing Chemotherapy. Medical-Surgical Nursing Journal. 2023;12(1).
  18. 18. Kotronoulas G, Papadopoulou C, Burns-Cunningham K, Simpson M, Maguire R. A systematic review of the supportive care needs of people living with and beyond cancer of the colon and/or rectum. European Journal of Oncology Nursing. 2017;29:60-70.
  19. 19. Haller H, Winkler MM, Klose P, Dobos G, Kuemmel S, Cramer H. Mindfulness-based interventions for women with breast cancer: an updated systematic review and meta-analysis. Acta oncologica. 2017;56(12):1665-76.
  20. 20. Karagozoglu S, Kahve E. Effects of back massage on chemotherapy-related fatigue and anxiety: Supportive care and therapeutic touch in cancer nursing. Applied Nursing Research. 2013;26(4):210-7.
  21. 21. Chalela P, Munoz E, Inupakutika D, Kaghyan S, Akopian D, Kaklamani V, et al. Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial. Contemporary clinical trials communications. 2018;12:109-15.
  22. 22. Kroenke CH, Hershman DL, Gomez SL, Adams SR, Eldridge EH, Kwan ML, et al. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast cancer research and treatment. 2018;170:623-31.
  23. 23. Gonen G, Kaymak SU, Cankurtaran ES, Karslioglu EH, Ozalp E, Soygur H. The factors contributing to death anxiety in cancer patients. Journal of psychosocial oncology. 2012;30(3):347-58.
  24. 24. Beydag KD. Factors affecting the death anxiety levels of relatives of cancer patients undergoing treatment. Asian Pacific Journal of Cancer Prevention. 2012;13(5):2405-8.
  25. 25. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani A, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 Iranian Journal of Rehabilitation Research. 2015;1(3):24-32.
  26. 26. Moharamzad Y, Saadat H, Shahraki BN, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Iranian hypertensive patients. Global journal of health science. 2015;7(4):173.
  27. 27. Tan X, Patel I, Chang J. Review of the four item Morisky medication adherence scale (MMAS-4) and eight item Morisky medication adherence scale (MMAS-8). INNOVATIONS in pharmacy. 2014;5(3):5.
  28. 28. McMordie WR. Improving measurement of death anxiety. Psychological Reports. 1979;44(3):975-80.
  29. 29. Tomás-Sábado J, Gómez-Benito J. Psychometric properties of the Spanish form of Templer's Death Anxiety Scale. Psychological reports. 2002;91(3_suppl):1116-20.
  30. 30. Nia HS, Ebadi A, Lehto RH, Mousavi B, Peyrovi H, Chan YH. Reliability and validity of the persian version of templer death anxiety scale-extended in veterans of Iran–Iraq warfare. Iranian journal of psychiatry and behavioral sciences. 2014;8(4):29.
  31. 31. Soleimani MA, Lehto RH, Negarandeh R, Bahrami N, Chan YH. Death anxiety and quality of life in Iranian caregivers of patients with cancer. Cancer nursing. 2017;40(1):E1-E10.
  32. 32. Nino de Guzman E, Song Y, Alonso-Coello P, Canelo-Aybar C, Neamtiu L, Parmelli E, et al. Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review. Breast cancer research and treatment. 2020;181:499-518.
  33. 33. Rust CF, Davis C, Moore MR. Medication adherence skills training for African-American breast cancer survivors: the effects on health literacy, medication adherence, and self-efficacy. Social work in health care. 2015;54(1):33-46.
  34. 34. Naseh L, Shirani A. larijani TT, dehkordi LM. Medical Specialties’ and Medical Students’ Vantage Points on Euthanasia. J Edu & Ethics Nurs. 2018;6(3):1-8.


         

صفحه اصلی

راهنمای نویسندگان

ارسال مقاله

تماس با ما